The present invention relates to a composite compact-type fat decomposition device, which is characterized in that fat in the epidermis of the skin is decomposed by a beam radiated from LEDs (310), fat in the dermis of the skin is decomposed by a beam radiated from a laser tube (100), and fat in the hypodermis of the skin is decomposed by a high frequency generated by an RF plate. The present invention includes: a handle (200) having a laser tube (100) therein and providing a grip; a rubber tab (230) coupled to a first end of the handle and protecting a power line; a ring-shaped LED PCB (300) coupled to a second end of the handle and equipped with LEDs (310); an RF plate support (400) having the LED PCB (300) on a first side and an RF plate (410) on a second side; the RF plate (410) decomposing fat by generating a high frequency; and a controller (500) controlling operations of the LEDs (310), the laser tube (100), and the RF plate (410), in which a beam radiated from the LEDs (310) decomposes fat in the epidermis of the skin, a beam radiated from the laser tube decomposes fat in the dermis of the skin, and the high frequency generated by the RF plate (410) decomposes fat in the hypodermis of the skin.

Optogenetic signal processing is described for an auditory prosthesis with an intracochlear array of optical stimulation sources implanted in a patient having auditory neurons genetically modified with light sensitive ion channels. Stimulation timing signals are generated for the corresponding auditory neurons for each band pass signal based on characteristic temporal fine structure features of the band pass signals. The stimulation timing signals include: i. one or more channel opening signals adapted to open the ion channels of the corresponding auditory neurons, and ii. one or more channel closing signals adapted to close the ion channels of the corresponding ion channels. Optical stimulation signals are then produced for the optical stimulation sources based on the stimulation timing signals.

A light irradiation apparatus includes first and second light sources that emit first light and second light, respectively. The first and the second lights have mutually different wavelengths at timings close to each other, regardless of overlap between the first light and the second light. The first light has a wavelength band for inducing destruction of bacteria by damaging a cell of the bacteria as the first light acts on a photosensitizer present in the bacteria. The second light has a wavelength band for inducing the destruction of the bacteria by changing the structure of a genetic material present in the cell of the bacteria. A dose of the second light source is less than 1/10 of a dose of the first light source.

The flashing light and cognitive therapy or video display presented on a mobile device or another screen used together to treat Alzheimer's disease and improve the brain's function.

A laser therapy apparatus can include a printed circuit board, a power supply, a controller, and a plurality of light sources electrically coupled to the printed circuit board and powered by the power supply. The plurality of light sources can include at least one laser diode. The laser therapy apparatus can further include a flexible translucent liner having an integrated flap at the periphery of the flexible translucent liner where the integrated flap is configured to retain a peripheral edge of a cap body shell for the laser therapy apparatus.

A light-based epilation device having at least two sub-groups of light emission elements, each of the sub-groups of light emission elements having at least one distinct light emission element, wherein the sub-groups of light emission elements are arranged for separate energizing, and a controller unit arranged for energizing the sub-groups of light emission elements in accordance with an energizing sequence so that the light emission unit quasi-continuously emits light

A device for activating light-induced rupture of endocytic vesicles in target cells of a patient so as to effect delivery of an administered antigen to cytosol in the target cells, is described. The device is adapted to be worn by a patient over a region of skin where an antigen and a photosensitising agent are to be administered. The device comprises a rear surface that is rounded or otherwise configured to be worn against the patient's skin. It has a retaining part for retaining the device in place over the region of the patient's skin during an activation cycle. A light source is arranged to illuminate the patient's skin from the rear of the device. A control system is configured to vary the output of the light source with respect to time in accordance with a pre-configured output sequence.

Devices and methods for low-level laser light therapy for animals and plants are provided. A device can include a pulse generator configured to generate a pulse train, wherein a pulse wave of the pulse train is configured to have a rectangular, non-sinusoidal waveform and a duty cycle within a range of 0.5% and 20%, an emitter array comprising a plurality of light emitting diodes (LEDs) and in electrical connection with the pulse generator, a computer-readable medium comprising stored instructions which, when executed, cause an LED to emit light, and a housing unit.

This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.

A wound bandage for administering light therapy is provided. The wound bandage may comprise a coated disposable flexible circuit. The disposable flexible circuit may comprise a set of plastic light-emitting diodes (LEDs). The disposable flexible circuit may be perforated and the set of LEDs may comprise at least one LED configured to emit light with a wavelength. The wound bandage may comprise a medical-grade adhesive disposed on a surface of the wound bandage. The adhesive may be configured to attach the wound bandage to a user's skin and maintain the wound bandage in a desired area. The wound bandage may comprise a socket configured to receive a connector coupled to an external control unit. The socket may transmit a control signal from the control unit to the set of LEDs and the control signal may pulse the set of LEDs at a frequency and a duty cycle.